EP-1353: Phase I/II study of hypofractionated Tomotherapy with CTMRI planning for prostate cancer. (April 2016) - Spera, A.; Mannino, M.; Mortellaro, G.; Figlia, V.; Caminiti, G.; Iacoviello, G.; Luca, N.; Cuccia, F.; Mazzola, R.; Ferrera, G.